Neuraminidase inhibitors: the story behind the Cochrane review
Author(s)
Doshi, Peter
Date Issued
December 2009
Journal
British Medical Journal
Publisher
British Medical Association
Citation
Doshi, Peter. “Neuraminidase inhibitors--the story behind the Cochrane review.” BMJ 339.dec07_2 (2009): b5164.
Version
Final published version
Abstract
Although billions have been spent on oseltamivir in the face of pandemic influenza, the team updating the Cochrane review of neuraminidase inhibitors in healthy adults found that the public evidence base for this global public health drug was fragmented and inconsistent. Peter Doshi tells the story
MIT Department
Massachusetts Institute of Technology. Program in History, Anthropology, and Science, Technology, and Society
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
http://dx.doi.org/10.1136/bmj.b5164
